FB2025_01 , released February 20, 2025
Reference Report
Open Close
Reference
Citation
Jarabo, P., de Pablo, C., Herranz, H., Martín, F.A., Casas-Tintó, S. (2021). Insulin signaling mediates neurodegeneration in glioma.  Life Sci Alliance 4(3): e202000693.
FlyBase ID
FBrf0248000
Publication Type
Research paper
Abstract
Cell to cell communication facilitates tissue development and physiology. Under pathological conditions, brain tumors disrupt glia-neuron communication signals that in consequence, promote tumor expansion at the expense of surrounding healthy tissue. The glioblastoma is one of the most aggressive and frequent primary brain tumors. This type of glioma expands and infiltrates into the brain, causing neuronal degeneration and neurological decay, among other symptoms. Here, we describe in a Drosophila model how glioblastoma cells produce ImpL2, an antagonist of the insulin pathway, which targets neighboring neurons and causes mitochondrial disruption as well as synapse loss, both early symptoms of neurodegeneration. Furthermore, glioblastoma progression requires insulin pathway attenuation in neurons. Restoration of neuronal insulin activity is sufficient to rescue synapse loss and to delay the premature death caused by glioma. Therefore, signals from glioblastoma to neuron emerge as a potential field of study to prevent neurodegeneration and to develop anti-tumoral strategies.
PubMed ID
PubMed Central ID
PMC7898663 (PMC) (EuropePMC)
Associated Information
Comments
Associated Files
Other Information
Secondary IDs
    Language of Publication
    English
    Additional Languages of Abstract
    Parent Publication
    Publication Type
    Journal
    Abbreviation
    Life Sci Alliance
    Title
    Life science alliance
    ISBN/ISSN
    2575-1077
    Data From Reference